TheProfitWatch

NAMS - NewAmsterdam Pharma Company N.V. Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
37.53 2.87 (7.65%) --- --- 0.0 (0.0%) -0.03 (-0.08%) 2.64 (6.98%) 0.16 (0.4%) 0.16 (0.4%)

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.15
Diluted EPS:
-0.15
Basic P/E:
-269.3333
Diluted P/E:
-269.3333
RSI(14) 1m:
0.0
VWAP:
40.4
RVol:
2.3284

Events

Period Kind Movement Occurred At
Day Rvol 2 increase day rvol 2.0, 40.5 +2.97 (+7.91%) Oct 15 15:40
1m Price increase 1m 41.1 +0.44 (+1.08%) Oct 15 15:11
1m Price decrease 1m 40.93 -0.48 (-1.15%) Oct 15 12:29
Day Price increase day 41.43 +3.89 (+10.38%) Oct 15 12:24
1m Price increase 1m 40.28 +0.4 (+1.0%) Oct 15 11:00

Related News